T40SN26-1-03 — SPB Tirzepatide
Awaiting TestSPB | Tirzepatide, last activity 2 months ago
A community group test is in progress for this batch.
A community group test is forming for this batch. SPB rarely publishes certificates across its inventory, though its vendor results average 99.72%. First seen one to three months ago, this batch has no independent testing or community reports recorded.
8 related batch concerns · summary from 3 sources · updated Aug 15
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
No independent test result yet.
Related batches
3 of 5 tested
also SPB
SPB rarely publishes certificates, and this batch has two quality concerns reported against it
KLOW, same vendor
An independent test found endotoxin at 49 EU/vial, over the 10 EU/vial working limit
GYC/GGpeps
Endotoxin levels have exceeded the 10 EU/vial working limit in two independent Janoshik tests (17.116 and 47.923…
also SPB
Three community reports describe problems with this batch, and a group test has shipped to Vanguard Laboratory for…
also SPB
One community report describes a problem with this batch
Group Tests
* Now Recruiting * T40 SN26-1-03 blue cap https://t.me/+kr3zu--IpWNjNjFh
SPB Telegram → Voluntary Testing
Updated 2 months ago
Community Intelligence
- 2 concern reports involving SN26XY-1-02
- 3 concern reports involving T10SN26LY-1-01
- 1 concern report involving T30SN26XY-1-02
- 2 concern reports involving KL8026LY-1C
- 3 concern reports involving EPI10SJ26-1-01
- 2 concern reports involving SJ26LY-1-01
- 1 concern report involving SJ26-4-01
- 1 concern report involving 2026061030
Reported against other SPB Tirzepatide batches, not this one.
Also known as: T40SN26103
Activity
No community activity tracked yet.
Vendor
SPB